Table 1.
Correlation between median OS and clinical and pathological factors in patients with resected pancreatic cancer
| Factor | n | OS (95% CI) | P value |
|---|---|---|---|
| Age | 0.675 | ||
| ≥65 years | 47 | 19 (13.07–27) | |
| <64 years | 42 | 19 (12–26) | |
| Sex | 0.7544 | ||
| Male | 57 | 23 (13.07–30.17) | |
| Female | 32 | 14 (10–24.2) | |
| pT category | 0.0019 | ||
| pTl/pT2/pT3 | 55 | 23 (16.30–43) | |
| p4 | 33 | 12 (9.43–19) | |
| pN category | 0.0070 | ||
| pN0 | 26 | 43 (16.93–) | |
| pN1 | 62 | 13.27 (11.6–22) | |
| Histological grade | 0.0804 | ||
| G1 | 19 | 31 (9–) | |
| G2 | 33 | 23 (14–30.16) | |
| G3 | 35 | 12 (10–23) | |
| Residual tumor | <0.0001 | ||
| R0 | 53 | 26 (19–45) | |
| R1 | 34 | 12 (9–13.73) | |
| Vessel invasion | 0.0204 | ||
| Positive | 57 | 13.73 (12–23) | |
| Negative | 31 | 27 (15–) | |
| Lymphatic invasion | 0.3004 | ||
| Positive | 76 | 15 (12–24.2) | |
| Negative | 18 | 27 (14.53–) | |
| Neural invasion | 0.6849 | ||
| Positive | 73 | 16.93 (13.07–26) | |
| Negative | 15 | 23 (4.7–) | |
| Adjuvant therapy | 0.0382 | ||
| Yes | 59 | 23 (14.53–30.17) | |
| No | 30 | 12 (7.7–24.2) |
OS overall survival, CI confidence interval